Reference
|
Number of Patients
|
Mutation Prevalence
|
Impact on Survival
|
---|
[46]
|
92
|
7 (7.6%)
|
Yes* (p-NR)
|
[47]
|
42
|
2 (4.8%)
|
NR
|
[48]
|
66
|
23 (24.8%)
|
No (p-0.258 – Univariate)
Yes (p-0.026 – Multivariate)
|
[49]
|
70
|
7 (10%)
|
Yes (p-0.03)
|
-
NR Not reported; * Survival analysis was done in patients harboring SETBP1 or JAK3 mutations compared to patients without either mutation